Comparison of Four Different Assays for Determination of Serum S-100B
暂无分享,去创建一个
[1] R. Donato,et al. Intracellular and extracellular roles of S100 proteins , 2003, Microscopy research and technique.
[2] G. D. de Gast,et al. Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma , 2003, Melanoma research.
[3] C. Heizmann,et al. S100 proteins: structure, functions and pathology. , 2002, Frontiers in bioscience : a journal and virtual library.
[4] Martin F. Mihm,et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] L. Hansson,et al. Serum S-100b protein as a prognostic marker in malignant cutaneous melanoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] J. Bonfrer,et al. Monitoring malignant melanoma with the S-100B tumour marker. , 2001, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[7] K. Haglid,et al. A New Specific Method for Measuring S-100B in Serum , 2000, The International journal of biological markers.
[8] P. Hersey,et al. Evaluation of S-100beta assays for the prediction of recurrence and prognosis in patients with AJCC stage I-III melanoma. , 1999, Melanoma research.
[9] A. Hauschild,et al. S100B Protein Detection in Serum Is a Significant Prognostic Factor in Metastatic Melanoma , 1999, Oncology.
[10] D. Chan,et al. Analytical and clinical evaluation of an electrochemiluminescence immunoassay for the determination of CA 125. , 1998, Clinical chemistry.
[11] J. Bonfrer,et al. Serum S-100 has prognostic significance in malignant melanoma. , 1997, Anticancer research.
[12] C. Heizmann,et al. Ca(2+)-binding proteins S100A6 and S100B in primary cutaneous melanoma. , 1997, Journal of cutaneous pathology.
[13] L. Hansson,et al. Prognostic value of serum analyses of S‐100β protein in malignant melanoma , 1996 .
[14] D. Zimmer,et al. The S100 protein family: History, function, and expression , 1995, Brain Research Bulletin.
[15] B. Stoffel‐Wagner,et al. Clinical significance of serum S100 in metastatic malignant melanoma. , 1995, European journal of cancer.
[16] M. Zweig,et al. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.
[17] C. Laterre,et al. Particle counting immunoassay of S100 protein in serum. Possible relevance in tumors and ischemic disorders of the central nervous system. , 1988, Clinical chemistry.
[18] W Bablok,et al. Comparison of Several Regression Procedures for Method Comparison Studies and Determination of Sample Sizes Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part II , 1984, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.
[19] W. Bablok,et al. A New Biometrical Procedure for Testing the Equality of Measurements from Two Different Analytical Methods. Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part I , 1983, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.
[20] B. Moore. A soluble protein characteristic of the nervous system. , 1965, Biochemical and biophysical research communications.